Marc Rudoltz, based in Pittsfield, MA, US, is currently a Chief Medical Officer at Tango Therapeutics, bringing experience from previous roles at Blueprint Medicines, Immunomet Therapeutics, Windmil Therapeutics and Constellation Pharmaceuticals. Marc Rudoltz holds a 1994 - 1996 University of Pennsylvania School of Medicine. With a robust skill set that includes Infectious Diseases, Pharmaceutical Industry, Oncology, Cancer, Small Molecules and more, Marc Rudoltz contributes valuable insights to the industry. Marc Rudoltz has 4 emails and 1 mobile phone number on RocketReach.